Story Navigation
-
DiscoveryDisease AwarenessEmerging TechnologyOphthalmologyJul 15, 2021Investigating the myopia mystery
Two scientists from Basel are trying to shed light on why myopia is impacting more and more people.
Discovery -
DiscoveryCancerInnovationNovartis Institutes for BioMedical ResearchClinical TrialsSep 27, 2021Cancer research drives breast cancer treatment forward
Novartis team perseveres to develop more personalized approach to breast cancer therapy.
Discovery -
DiscoveryPatient VoicesRespiratoryClinical TrialsDrug DevelopmentJul 19, 2021Respiratory clinical trials: Putting patients at the heart of research
All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.
Discovery -
DiscoveryOncologyWomen in ScienceWorking at NovartisReimagine MedicineCareersJul 19, 2021Women in Science: Sandrine Piret-Gérard
Sandrine Piret-Gérard, Vice President and Head of US Hematology at Novartis, reflects on what’s inspired her career in health care.
Discovery -
Access to HealthcareDisease EradicationInfectious DiseasesMalariaNovartis Malaria InitiativeNovartis Social BusinessJul 20, 2021Asian health experts call for final push to wipe out deadliest form of malaria
The most lethal strain could be eliminated by 2030, but major hurdles remain.
Access to Healthcare -
DiseasesInnovationNovartis Institutes for BioMedical ResearchDrug DevelopmentJul 14, 2021Counting on combos for complex liver diseases
The best treatment for multifaceted diseases like NASH may be combinations of drugs.
-
Cell and Gene TherapyEye CareOphthalmologyReimagine MedicineGenetic DiseaseJul 12, 2021Bringing gene therapy into focus
Dr. Botond Roska says we should keep our eyes on gene therapy.
-
From Our LabsEye CareNovartis Institutes for BioMedical ResearchOphthalmologyEye DisordersJul 20, 2021What goes wrong with the window to the soul in glaucoma?
Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.
From Our Labs -
DiscoveryCell and Gene TherapyNovartis Institutes for BioMedical ResearchOphthalmologyClinical TrialsEye DisordersJul 14, 2021Experimental gene therapy discovered in-house enters clinical testing
Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.
Discovery -
DiscoveryCancerNovartis Institutes for BioMedical ResearchOncologyScientific ResearchJul 19, 2021Visualizing immuno-oncology research
Learn how Novartis researchers are working to outsmart tumors.
Discovery -
People and CultureInnovationWorking at NovartisCareersAug 10, 2021Enabling 130,000 employees to grow in an organization committed to continuous learning
Our Chief Learning Officer, Simon Brown, talks about our ongoing efforts to build new capabilities by investing in our own people.
People and Culture -
Access to HealthcareAccess to HealthcareChronic IllnessFuture of HealthcareNovartis AccessNovartis Social BusinessAug 11, 2021Novartis Access impact evaluation: progress update on our work with Boston University
Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.
Access to Healthcare
Pagination
- ‹ Previous page
- …
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- …
- › Next page